Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

RING finger-dependent ubiquitination by PRAJA is dependent on TGF-beta and potentially defines the functional status of the tumor suppressor ELF.

Saha T, Vardhini D, Tang Y, Katuri V, Jogunoori W, Volpe EA, Haines D, Sidawy A, Zhou X, Gallicano I, Schlegel R, Mishra B, Mishra L.

Oncogene. 2006 Feb 2;25(5):693-705.

PMID:
16247473
2.

The role of PRAJA and ELF in TGF-beta signaling and gastric cancer.

Mishra L, Katuri V, Evans S.

Cancer Biol Ther. 2005 Jul;4(7):694-9. Epub 2005 Jul 13. Review.

PMID:
16096365
3.

Adaptor proteins and ubiquinators in TGF-beta signaling.

Mishra L, Marshall B.

Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):75-87. Epub 2005 Dec 15.

PMID:
16359909
5.

Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression.

Katuri V, Tang Y, Li C, Jogunoori W, Deng CX, Rashid A, Sidawy AN, Evans S, Reddy EP, Mishra B, Mishra L.

Oncogene. 2006 Mar 23;25(13):1871-86.

6.

Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation.

Levy L, Howell M, Das D, Harkin S, Episkopou V, Hill CS.

Mol Cell Biol. 2007 Sep;27(17):6068-83. Epub 2007 Jun 25.

7.

Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.

Morén A, Imamura T, Miyazono K, Heldin CH, Moustakas A.

J Biol Chem. 2005 Jun 10;280(23):22115-23. Epub 2005 Apr 6.

8.

CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.

Xin H, Xu X, Li L, Ning H, Rong Y, Shang Y, Wang Y, Fu XY, Chang Z.

J Biol Chem. 2005 May 27;280(21):20842-50. Epub 2005 Mar 21.

9.

Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis.

Baek HJ, Lim SC, Kitisin K, Jogunoori W, Tang Y, Marshall MB, Mishra B, Kim TH, Cho KH, Kim SS, Mishra L.

Hepatology. 2008 Oct;48(4):1128-37. doi: 10.1002/hep.22460.

11.

Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation.

Yang L, Wang N, Tang Y, Cao X, Wan M.

Hum Mutat. 2006 Sep;27(9):897-905.

PMID:
16865698
12.

Inactivation of ELF/TGF-beta signaling in human gastrointestinal cancer.

Katuri V, Tang Y, Marshall B, Rashid A, Jogunoori W, Volpe EA, Sidawy AN, Evans S, Blay J, Gallicano GI, Premkumar Reddy E, Mishra L, Mishra B.

Oncogene. 2005 Dec 1;24(54):8012-24.

PMID:
16158060
13.

The four and a half LIM-only protein 2 (FHL2) activates transforming growth factor β (TGF-β) signaling by regulating ubiquitination of the E3 ligase Arkadia.

Xia T, Lévy L, Levillayer F, Jia B, Li G, Neuveut C, Buendia MA, Lan K, Wei Y.

J Biol Chem. 2013 Jan 18;288(3):1785-94. doi: 10.1074/jbc.M112.439760. Epub 2012 Dec 4.

14.

Differential ubiquitination defines the functional status of the tumor suppressor Smad4.

Morén A, Hellman U, Inada Y, Imamura T, Heldin CH, Moustakas A.

J Biol Chem. 2003 Aug 29;278(35):33571-82. Epub 2003 Jun 5.

15.

Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma.

Fukasawa H, Yamamoto T, Fujigaki Y, Misaki T, Ohashi N, Takayama T, Suzuki S, Mugiya S, Oda T, Uchida C, Kitagawa K, Hattori T, Hayashi H, Ozono S, Kitagawa M, Hishida A.

Int J Cancer. 2010 Oct 1;127(7):1517-25. doi: 10.1002/ijc.25164.

16.

Regulation of TGF-beta family signaling by E3 ubiquitin ligases.

Inoue Y, Imamura T.

Cancer Sci. 2008 Nov;99(11):2107-12. doi: 10.1111/j.1349-7006.2008.00925.x. Epub 2008 Sep 18. Review.

17.

Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation.

Kitisin K, Ganesan N, Tang Y, Jogunoori W, Volpe EA, Kim SS, Katuri V, Kallakury B, Pishvaian M, Albanese C, Mendelson J, Zasloff M, Rashid A, Fishbein T, Evans SR, Sidawy A, Reddy EP, Mishra B, Johnson LB, Shetty K, Mishra L.

Oncogene. 2007 Nov 1;26(50):7103-10. Epub 2007 Jun 4.

18.

Oncogenic ras represses transforming growth factor-beta /Smad signaling by degrading tumor suppressor Smad4.

Saha D, Datta PK, Beauchamp RD.

J Biol Chem. 2001 Aug 3;276(31):29531-7. Epub 2001 May 22.

19.

Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.

Mishra B, Tang Y, Katuri V, Fleury T, Said AH, Rashid A, Jogunoori W, Mishra L.

Liver Int. 2004 Dec;24(6):637-45.

PMID:
15566516
20.

Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis.

Tang Y, Katuri V, Srinivasan R, Fogt F, Redman R, Anand G, Said A, Fishbein T, Zasloff M, Reddy EP, Mishra B, Mishra L.

Cancer Res. 2005 May 15;65(10):4228-37.

Supplemental Content

Support Center